Table 2.
Clinical characteristics in 3 study groups
| Maternal outcomes | Severe Preeclampsia (n=903) | Eclampsia (n=123) | HELLP syndrome (n=196) | p |
|---|---|---|---|---|
| Maternal morbidity | 35 (3.9%) | 15 (12.2%) | 29 (14.8%) | p<0.0001 |
| ARDS | 4 (0.4%) | 3 (2.4%) | 1 (0.5%) | 0.038 |
| Acute renal failure | 14 (1.6%) | 5 (4.1%) | 21 (10.7%) | p<0.0001 |
| Neurologic deficits | 1 (0.8%) | 3 (0.3%) | 2 (1%) | 0.0015 |
| Visual change | 6 (0.7%) | 6 (4.9%) | 1 (0.5%) | p<0.0001 |
| Pulmonary edema | 5 (0.6%) | 0 | 2 (1%) | 0.496 |
| Ascites | 3 (0.3%) | 0 | 1 (0.5%) | 0.738 |
| Intracranial hemorrhage | 0 | 0 | 1 (0.5%) | 0.072 |
| Abruptio placentae | 64 (7.1%) | 10 (8.1%) | 18 (9.2%) | 0.581 |
| Cesarean delivery | 617 (68.3%) | 105 (86.3%) | 150 (76.5%) | 0.005 |
| Maternal death | 1 (0.1%) | 0 | 1 (0.5%) | 0.407 |
According to the χ2 test for trend